108 related articles for article (PubMed ID: 34906280)
1. Polyphenol-Based Paclitaxel Prodrug Self-Assembled Nanoplatform for Tumor Synergistic Therapy.
Rong G; Xu M; Shi S; Yao Q; Cheng W; Sang D; Yu W; Qian Y; Shan L
J Biomed Nanotechnol; 2021 Nov; 17(11):2198-2209. PubMed ID: 34906280
[TBL] [Abstract][Full Text] [Related]
2. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
Wang W; Xi M; Duan X; Wang Y; Kong F
Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
[TBL] [Abstract][Full Text] [Related]
3. Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy.
Wang W; Fan J; Zhu G; Wang J; Qian Y; Li H; Ju J; Shan L
Int J Nanomedicine; 2020; 15():2921-2933. PubMed ID: 32425524
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-Paclitaxel Prodrug Nanoassembly as a Versatile Nanoplatform for Combinational Cancer Therapy.
Han X; Chen J; Jiang M; Zhang N; Na K; Luo C; Zhang R; Sun M; Lin G; Zhang R; Ma Y; Liu D; Wang Y
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33506-33513. PubMed ID: 27960378
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-Induced Ultrasmall Gallic Acid-Fe@BSA Self-Assembly with Enhanced MRI Performance and Tumor Accumulation for Cancer Theranostics.
An L; Yan C; Mu X; Tao C; Tian Q; Lin J; Yang S
ACS Appl Mater Interfaces; 2018 Aug; 10(34):28483-28493. PubMed ID: 30080382
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
8. Probing the fluorination effect on the self-assembly characteristics,
Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J
Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971
[No Abstract] [Full Text] [Related]
9. Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy.
Dong C; Zhou Q; Xiang J; Liu F; Zhou Z; Shen Y
J Control Release; 2020 May; 321():529-539. PubMed ID: 32109513
[TBL] [Abstract][Full Text] [Related]
10. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
11. An activatable fluorescent prodrug of paclitaxel and BODIPY.
Xia J; Pei Q; Zheng M; Xie Z
J Mater Chem B; 2021 Mar; 9(9):2308-2313. PubMed ID: 33616144
[TBL] [Abstract][Full Text] [Related]
12. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity.
Cheng Y; Ji Y
J Control Release; 2020 Feb; 318():38-49. PubMed ID: 31830542
[TBL] [Abstract][Full Text] [Related]
14. Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates.
Guo T; Zhong H; Li X; Mu J; Liu T; Yu N; Zhao Y; Liang XJ; Guo S
J Control Release; 2023 Jul; 359():175-187. PubMed ID: 37271184
[TBL] [Abstract][Full Text] [Related]
15. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
[TBL] [Abstract][Full Text] [Related]
16. iRGD-paclitaxel conjugate nanoparticles for targeted paclitaxel delivery.
Hu H; Wang B; Lai C; Xu X; Zhen Z; Zhou H; Xu D
Drug Dev Res; 2019 Dec; 80(8):1080-1088. PubMed ID: 31411346
[TBL] [Abstract][Full Text] [Related]
17. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
Cherukula K; Uthaman S; Park IK
Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
[TBL] [Abstract][Full Text] [Related]
18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled nanoparticles from hyaluronic acid-paclitaxel prodrugs for direct cytosolic delivery and enhanced antitumor activity.
Xu C; He W; Lv Y; Qin C; Shen L; Yin L
Int J Pharm; 2015 Sep; 493(1-2):172-81. PubMed ID: 26232702
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
